SpringWorks Therapeutics
Stamford, United States (US) · Health and Medical
Do you work at SpringWorks Therapeutics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
SpringWorks Therapeutics is a US-based biopharmaceutical company of Merck KGaA, Darmstadt, Germany, dedicated to developing innovative treatments for patients with rare tumors.We’ve achieved FDA and EC approval for the first and only medicines for adults with desmoid tumors and the first and only medicines for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).At SpringWorks, we’re driven by a commitment to finding answers for those facing rare diseases, fueled by a culture of urgency and tenacity.
Overview
We’ve achieved FDA and EC approval for the first and only medicines for adults with desmoid tumors and the first and only medicines for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).
At SpringWorks, we’re driven by a commitment to finding answers for those facing rare diseases, fueled by a culture of urgency and tenacity. Our focus is on BCMA combinations in multiple myeloma and we are actively engaged in investigator-initiated research to unlock the full potential of targeted oncology.
We value authenticity and diversity, recognizing that a wide range of perspectives is essential to our mission of improving patient outcomes.
Contact Details
Stamford, United States (US), 100 Washington Blvd
+1
Founded
2017
Company Type
Public Limited Company
Employees
200-500
Categories
Products
Companies teams usually look at after SpringWorks Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.